Cervical cancer remains one of the few cancers that can potentially be eliminated through human papillomavirus (HPV) vaccination, regular screening and timely treatment of precancerous changes. Despite the availability of effective prevention and treatment measures, global deaths from cervical cancer are projected to increase by nearly 40% by 2050, according to a study involving researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.
Singapore sees 65% decline in cervical cancer mortality rate since 1990, but screening gaps remain
Singapore has achieved a 65% decline in cervical cancer mortality since 1990 through HPV vaccination and screening programs, yet global cervical cancer deaths are projected to increase 40% by 2050 due to screening gaps. The article discusses prevention strategies through vaccination and early detection, with research from NUS Medicine and IHME highlighting the importance of accessible healthcare infrastructure.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%